Publications by authors named "Sun Yonghu"

Background: Severe cutaneous adverse reactions (SCARs) mediated by cytotoxic T lymphocytes are a series of life-threatening conditions with a mortality of 4%-20%. The clinical application of tumor necrosis factor-alpha (TNF-α) antagonist improves the outcome of some SCARs patients; however, this is complicated by the elusive and varied immunopathogenesis.

Aim: To investigate whether IgE antibody responses to HEMAs are associated with AD, its severity, and response to dupilumab.

View Article and Find Full Text PDF

Background: High positivity rate of skin phosphorylated α-synuclein (P-SYN) was observed in Parkinson's disease (PD). Bullous pemphigoid (BP) is one of the most common autoimmune skin diseases associated with PD.

Objectives: Our aim was to investigate whether BP patients might be a targeted risk population for the screening of skin P-SYN.

View Article and Find Full Text PDF

Recent studies have shown that local injection of secukinumab can achieve positive therapeutic effects when applied in the treatment of nail psoriasis. At present, there have been no other studies on the use of biological agents in the treatment of pediatric nail psoriasis. Three children were included in the study to evaluate the efficacy and safety of periungual injection and long-term injection of secukinumab in the treatment of nail psoriasis in children.

View Article and Find Full Text PDF

Biological agents are widely used across medicine, including for immune-mediated skin conditions such as psoriasis and atopic dermatitis. When used to treat a relevant pathological process, they demonstrate impressive efficacy and credible safety, helping to achieve remission and improved function and quality of life. However, with their expanded use, awareness and understanding of adverse reactions to biologicals have also increased.

View Article and Find Full Text PDF
Article Synopsis
  • Biological agents and small molecule drugs have improved treatment for psoriasis, but there's a gap in understanding how these drugs affect mental disorders (MDs) and vice versa.
  • A systematic review analyzed 116 studies, showing that psoriasis medications generally improve MD symptoms while some MD treatments negatively impact psoriasis.
  • Notably, TNF-α inhibitors and interleukin inhibitors are more effective than traditional treatments, with secukinumab and ixekizumab showing significant benefits for anxiety and depression, respectively, despite limitations in data standardization.
View Article and Find Full Text PDF
Article Synopsis
  • Pityriasis rubra pilaris (PRP) is a skin condition marked by inflamed, scaly patches, and its exact causes are still not fully understood.
  • A study involving 102 PRP patients and 800 healthy individuals found significant links between PRP and mutations in the Keratin 32 gene (KRT32), which helps regulate skin inflammation.
  • These findings suggest that KRT32 mutations might contribute to PRP development by leading to increased inflammation, and highlight the potential for KRT32 as a target for new treatments.
View Article and Find Full Text PDF

Bullous pemphigoid (BP) is a type 2 inflammation- and immunity-driven skin disease, yet a comprehensive understanding of the immune landscape, particularly immune-stromal crosstalk in BP, remains elusive. Herein, using single-cell RNA sequencing (scRNA-seq) and in vitro functional analyzes, we pinpoint Th2 cells, dendritic cells (DCs), and fibroblasts as crucial cell populations. The IL13-IL13RA1 ligand-receptor pair is identified as the most significant mediator of immune-stromal crosstalk in BP.

View Article and Find Full Text PDF
Article Synopsis
  • Linear IgA bullous dermatosis (LABD) and dermatitis herpetiformis (DH) are types of autoimmune skin disorders linked to IgA, and this study aimed to explore their causes using serum proteomics.
  • Researchers analyzed 92 biomarkers in serum samples from LABD, DH patients, and healthy controls, discovering elevated levels of certain biomarkers specific to these conditions.
  • The study identified distinct biomarker clusters for LABD and DH, with six specific biomarkers showing potential for better prognosis in DH patients, which could help differentiate these disease subtypes in the future.
View Article and Find Full Text PDF
Article Synopsis
  • Genome-wide association studies (GWASs) have identified 35 genetic loci related to leprosy, but their combined effect only partially explains the disease risk, with unknown causal variants and genes.
  • A new GWAS analyzing over 10,000 participants found 3 new and 15 previously reported risk loci, increasing the explained genetic heritability of leprosy from 23% to 38.5%.
  • Fine-mapping analysis revealed 19 causal variants and 14 genes, primarily linked to immune regulatory elements, highlighting the importance of immune-related pathways in leprosy development.
View Article and Find Full Text PDF

Epidermal growth factor receptor inhibitors (EGFRIs) are widely used to treat various types of malignancies. One of the common adverse reactions is cutaneous toxicity, mostly presenting as acneiform eruptions, paronychia and xerosis. Erosive pustular dermatosis of the scalp (EPDS) is a rare cutaneous adverse reaction that develops during treatment with EGFRIs.

View Article and Find Full Text PDF

Background: M. leprae preferentially infects Schwann cells (SCs) in the peripheral nerves leading to nerve damage and irreversible disability. Knowledge of how M.

View Article and Find Full Text PDF

Dapsone hypersensitivity syndrome (DHS) is restricted to HLA-B∗13:01. However, the positive predictive value for HLA-B∗13:01 is only 7.8%.

View Article and Find Full Text PDF

Pathogen-induced epigenetic modifications can reshape anti-infection immune processes and control the magnitude of host responses. DNA methylation profiling has identified crucial aberrant methylation changes associated with diseases, thus providing biological insights into the roles of epigenetic factors in mycobacterial infection. In this study, we performed a genome-wide methylation analysis of skin biopsies from patients with leprosy and healthy controls.

View Article and Find Full Text PDF

Previous studies have shown that cysteine-reactive drug metabolites bind covalently with protein to activate patient T cells. However, the nature of the antigenic determinants that interact with HLA and whether T cell stimulatory peptides contain the bound drug metabolite has not been defined. Because susceptibility to dapsone hypersensitivity is associated with the expression of HLA-B*13:01, we have designed and synthesized nitroso dapsone-modified, HLA-B*13:01 binding peptides and explored their immunogenicity using T cells from hypersensitive human patients.

View Article and Find Full Text PDF

Drug-responsive T-cells are activated with the parent compound or metabolites, often via different pathways (pharmacological interaction and hapten). An obstacle to the investigation of drug hypersensitivity is the scarcity of reactive metabolites for functional studies and the absence of coculture systems to generate metabolites in situ. Thus, the aim of this study was to utilize dapsone metabolite-responsive T-cells from hypersensitive patients, alongside primary human hepatocytes to drive metabolite formation, and subsequent drug-specific T-cell responses.

View Article and Find Full Text PDF

The discovery of pathogenic variants provided biological insight into the role of host genetic factors in generalized pustular psoriasis (GPP). However, not all those affected by GPP carry variants in the reported genes. To comprehensively explore the molecular pathogenesis of GPP, whole-exome sequencing was performed, and two loci were identified with exome-wide significance through single variant association analysis: rs148755083 in the IL36RN gene (P = 1.

View Article and Find Full Text PDF